Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder.

CONTEXT On January 31, 2008, the Food and Drug Administration issued an alert regarding increased risk of suicidal thoughts and behavior related to use of antiepileptic drugs (AEDs). On July 10, 2008, a Food and Drug Administration scientific advisory committee voted that, yes, there was a significant positive association between AEDs and suicidality but voted against placing a black box warning on AEDs for suicidality. OBJECTIVE To determine if AEDs increase the risk of suicide attempt in patients with bipolar disorder. DESIGN A pharmacoepidemiologic study in which suicide attempt rates were compared before and after treatment and with a medication-free control group. Analyses were restricted to AED and lithium monotherapy. SETTING We used the PharMetrics medical claims database to study the relationship between the 11 AEDs identified in the FDA alert, and lithium, to suicide attempts. MAIN OUTCOME MEASURE Suicide attempts. Patients A cohort of 47 918 patients with bipolar disorder with a minimum 1-year window of information before and after the index date of their illness. RESULTS Overall, there was no significant difference in suicide attempt rates for patients treated with an AED (13 per 1000 person-years [PY]) vs patients not treated with an AED or lithium (13 per 1000 PY). In AED-treated subjects, the rate of suicide attempts was significantly higher before treatment (72 per 1000 PY) than after (13 per 1000 PY). In patients receiving no concomitant treatment with an antidepressant, other AED, or antipsychotic, AEDs were significantly protective relative to no pharmacologic treatment (3 per 1000 vs 15 per 1000 PY). CONCLUSIONS Despite Food and Drug Administration reports regarding increased risk of suicidality associated with AED treatment, the current study reveals that, as a class, AEDs do not increase risk of suicide attempts in patients with bipolar disorder relative to patients not treated with an AED or lithium. Use of AEDs reduces suicide attempt rates both relative to patients not receiving any psychotropic medication and relative to their pretreatment levels.

[1]  B. Efron Logistic Regression, Survival Analysis, and the Kaplan-Meier Curve , 1988 .

[2]  D. Rubin,et al.  The central role of the propensity score in observational studies for causal effects , 1983 .

[3]  R. Baldessarini,et al.  Suicide in Bipolar Disorder: Risks and Management , 2006, CNS Spectrums.

[4]  F. Goodwin Anticonvulsant therapy and suicide risk in affective disorders. , 1999, The Journal of clinical psychiatry.

[5]  R. Baldessarini,et al.  Lower suicide risk with long‐term lithium treatment in major affective illness:
a meta‐analysis , 2001, Acta psychiatrica Scandinavica.

[6]  H. Lôo [On bipolar disorder]. , 2008, L'Encephale.

[7]  P. Andersen,et al.  Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. , 2008, Bipolar disorders.

[8]  F. Goodwin Paroxetine in the Treatment of Primary Insomnia: Preliminary Clinical and Electroencephalogram Sleep Data , 1999 .

[9]  Peter C Austin,et al.  A critical appraisal of propensity‐score matching in the medical literature between 1996 and 2003 , 2008, Statistics in medicine.

[10]  Frederick K Goodwin,et al.  Suicide risk in bipolar disorder during treatment with lithium and divalproex. , 2003, JAMA.

[11]  P. Andersen,et al.  Suicide risk in patients treated with lithium. , 2005, Archives of general psychiatry.

[12]  B. Mcfarland,et al.  Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. , 2008, Journal of affective disorders.

[13]  J. Mann,et al.  Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. , 2007, The American journal of psychiatry.

[14]  Esben Agerbo,et al.  Epilepsy and risk of suicide: a population-based case–control study , 2007, The Lancet Neurology.

[15]  Barbara Stanley,et al.  Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. , 2007, The American journal of psychiatry.

[16]  Dorothy Nelkin,et al.  Waiting for organ transplantation: results of an analysis by an Institute of Medicine Committee. , 2003, Biostatistics.

[17]  R. Baldessarini,et al.  Suicide risk and treatments for patients with bipolar disorder. , 2003, JAMA.